Health Condition 1: L400- Psoriasis vulgaris
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Dr Sathish Suriyaprakasam
Eligibility
Inclusion criteria
Inclusion criteria: Patients must be diagnosed with mild psoriasis, defined as having a body surface area (BSA) of less than 10%. Controls: Patients attending Dermatology OPD/STD OPD due to the disorders neither associated with nor prone to develop metabolic syndrome such as keloid, eczema, Sexually transmitted infections and normal patient attenders.
Exclusion criteria
Exclusion criteria: Patients with psoriasis >10% BSA Patients on phototherapy and systemic medications for psoriasis Patients with Nail psoriasis, Psoriatic arthritis Patients who are currently taking medications for any medical condition that may affect the prevalence of Metabolic syndrome. Patients with pro-inflammatory skin conditions such as Acne, Atopic dermatitis, Alopecia, lichen planus, vitiligo, autoimmune disorders. Patients who are not willing to consent for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To estimate the prevalence of Metabolic syndrome in Mild psoriasisTimepoint: Single cross sectional assessment over a study period of one year | — |
Secondary
| Measure | Time frame |
|---|---|
| To elicit the variations in prevalence of metabolic syndrome as per age, gender, duration of psoriasis, socio-economic status, physical activity and dietary habitsTimepoint: Single cross sectional assessment over a study period of one year | — |
Countries
India
Contacts
Public ContactDr Vijaya Anand Muthupandi
Madurai Medical College
Outcome results
None listed